High levels of factor VIIIc and risk of venous thrombosis: Critical analysis of case-control studies;Elévation du facteur VIIIc coagulant et risque de thrombose veineuse: Analyse critique des études cas-témoins

Revue de Medecine Interne

Volumn 24, Issue 6, 2003, Pages 366-371

  Benjaber, K ^a   Constans, J ^b   Cougnard, A ^a   Salmi, L R ^a  

^a INSERM   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Deep venous thrombosis; High levels of factor VIII

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 8; PROTEIN C; PROTEIN S;

ADULT; AGED; CARDIOVASCULAR RISK; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; REVIEW; RISK FACTOR; SCREENING;

EID: 0038141763     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(02)00806-8     Document Type: Short Survey

References (31)

1. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 1991;151:933-8.
2. Heijboer H, Brandjes DP, Buller HR, Sturk A, Ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990;323:1512-6.
3. Bertina RM, Reistem PH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995;74:449-53.
4. Bertina RM. Factor V. Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 1997;43:1678-83.
5. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152-5.
6. Salmi LR. Lecture critique et rédaction médicale scientifique, Comment lire, rédiger et publier une étude clinique ou épidémiologique. Paris: Elsevier; 1998.
7. Hubbard AR, Rigsby P, Barrowcliffe TW. Standardisation of factor VIII and von Willebrand Factor in plasma: Calibration of the 4th International Standard (97/586). Thromb Haemost 2001;85:634-8.
8. Van der Meer FJM, Koster T, Vandenbroucke JP, Briet E, Rosendaal FR. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997;78:631-5.
9. Bloemenkamp KWM, Helmerhorst FM, Rosendaal FR, Vandenbroucke JP. Venous thrombosis, oral contraceptives and high factor VIII levels. Thromb Haemost 1999;82:1024-7.
10. Kamphuisen PW, Rosendaal FR, Eikenboom JCJ, Bos R, Bertina RM. Factor V antigen levels and venous thrombosis: Risk profile, interaction with factor V Leiden and relation with factor VIII antigen levels. Arterioscler Thromb Vasc Biol 2000;20:1382-6.
11. De Mitrio V, Marino R, Scaraggi FA, Di Bari L, Giannoccaro F, Petronelli M, et al. Influence of factor VIII/von Willebrand complex on the activated protein C resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation. Blood Coagul Fibrinol 1999;10:409-16.
12. Kraaijenhagen RA, In't Anker PS, Koopman MMW, Reitsma PH, Prins MH, Van den Ende A, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000;83:5-9.
13. Marcucci R, Abbate R, Fedi S, Gori AM, Brunelli T, Bruni V, et al. Acquired activated protein C resistance in postmenopausal women is dependent on factor VIIIc levels. Am J Clin Pathol 1999;111:769-72.
14. Lowe GDO, Rumley A, Woodward M, Reid E, Rumley J. Activated protein C resistance and the FV: R506Q mutation in a random population sample. Thromb Haemost 1999;81:918-24.
15. Lensen R, Bertina RM, Vandenbroucke JP, Rosendaal FR. High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden. Br J Haematol 2001;114:380-6.
16. Kyrle PA, Minar E, Hirschil M, Bialonczyk C, Stain M, Schneider B, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000;343:457-62.
17. Aiach M, Borgel D, Gaussem P, Emmerich J, Alhenc-Gelas M, Gandrille S. Protein C and Protein S deficiencies. Semin Hematol 1997;34:205-17.
18. Hirsh J, Piovella F, Pini M. Congenital antithrombine III deficiency: incidence and clinical features. Am J Med 1998;87:34s-8s.
19. Martinelli BA, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: A Study of 150 families. Blood 1998;92:2353-8.
20. De Stephano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: clinical implications. Semin. Thromb Haemost 1998;24:367-79.
21. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-8.
22. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD. Hypercoagulability in centenarians: the paradox of successful aging. Blood 1995;11:3144-9.
23. Kelly DA, O'Brien FJ, Hutton RA, Tuddenham EG, Summerfield JA, Scherlock S. The effect of liver disease on factors V, VIII and protein C. Br J Haematol 1985;61:541-8.
24. O'Donnell J, Tuddenham EGD, Manning R, Kemball C, Johnson D, Laffan M. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 1999;81:680-3.
25. O'Donnell J, Mumford AD, Manning RA, Laffan M. Elevation of FVIIIc in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost 2000;83:10-3.
26. Kamphuisen PW, Houwing-Duistermaat JJ, van Houwelingen HC, Eikenboom JCJ, Bertina RM, Rosendaal FR. Familial clustering of factor VIII and von Willebrand factor levels. Thromb Haemost 1998;79:323-7.
27. Mansvelt EPG, Laffan M, Mc Vey JH, Tuddenham EGD. Analysis of the F8 gene in individuals with high plasma factor VIIIc levels and associated venous thrombosis. Thromb Haemost 1998;80:561-5.
28. Kamphuisen PW, Lensen R, Houwing-Duistermaat JJ, Eikenboom JCJ, Harvey M, Bertina RM, et al. Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia. Br J Haematol 2000;109:519-22.
29. Cattaneo M, Chantarangkul V, Taioli E, Santos JH, Tagliabue L. The G20210A mutation of the prothrombin gene in patients with previous first episode of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels. Thromb Res 1999;93:1-8.
30. Vlieg AVH, Van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000;95:3678-82.
31. Meijers JCM, Tekelenbourg WLH, Bonno MSC, Bouma N, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000;342:696-701.